Why the study?
Studies comparing the survival of patients undergoing hemodialysis versus peritoneal dialysis have yielded controversial results.
Does initial peritoneal dialysis compared to hemodialysis improve survival in patients with end-stage renal disease?
Does initial peritoneal dialysis compared to hemodialysis improve survival in patients with end-stage renal disease?
Initial dialysis modality (HD vs PD) does not significantly impact overall survival in ESRD patients, though PD may offer a survival advantage in diabetic patients.
Answers are grounded in this paper and cite their sources.
No survival difference between HD and PD overall; leaves open possible PD benefit in diabetics as hypothesis-generating.
Background Studies comparing survival of hemodialysis (HD) and peritoneal dialysis (PD) patients are controversial. This study evaluated the impact of initial dialysis modality on the survival of patients with end-stage renal disease (ESRD) in a matched-pair cohort. Methods A retrospective cohort study was performed on ESRD patients who initiated renal replacement treatment between January 1, 2010, and December 31, 2018. Propensity score matching was applied to balance the baseline conditions, and multivariate Cox regression analysis was applied to compare mortality between HD and PD patients and evaluate correlations between mortality and various baseline characteristics. Subgroup analysis was performed with respect to diabetes status. Results There were 739 patients in our center in the Chinese National Renal Data System (CNRDS) between 2010 and 2018. Of these, 125 PD patients were matched with 125 HD patients. The 1-, 2-, and 3-year survival rates were 96.5%, 90.7%, and 82.5%, respectively, in the HD group and 99.5%, 97.8%, and 92.5%, respectively, in the PD group (log-rank P < 0.001). Among the propensity score-matched cohorts, no significant differences in Kaplan–Meier curves were observed between the two groups (log-rank P = 0.514). Age at dialysis initiation, CCI, congestive heart failure and cerebrovascular disease were risk factors in the multivariable-adjusted model. In subgroups defined by diabetes status, the Kaplan‒Meier survival curve showed that PD survival was significantly higher than that of HD (log-rank P = 0.022). Conclusions HD and PD were not significantly different with regard to survival of patients with ESRD. PD was associated with better survival in diabetic ESRD patients.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: